Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.
Chataway J, Schuerer N, Alsanousi A, Chan D, Macmanus D, Hunter K, Anderson V, Bangham CRM, Clegg S, Nielsen C, et al.